Litcius/Paper detail

COVID-19 Infection in a Patient with End-Stage Kidney Disease

Dian Fu, Bo Yang, Jing Xu, Zhiguo Mao, Chenchen Zhou, Cheng Xue

2020˜The œNephron journals/Nephron journals52 citationsDOIOpen Access PDF

Abstract

Since December 2019, the epidemic of coronavirus disease 2019 (COVID-19) has spread very rapidly in China and worldwide. In this article, we report on a 75-year-old man infected with 2019 novel coronavirus who has end-stage kidney disease (ESKD). COVID-19 patients with ESKD need isolation dialysis, but most of them cannot be handled in time due to limited continuous renal replacement therapy (CRRT) machines. CRRT provided benefits for this patient by removing potentially damaging toxins and stabilizing his metabolic and hemodynamic status. With the control of uremia and fluid status, this patient ended up with an uneventful post-CRRT course, absence of clinical symptoms, and negative PCR tests. Greater efforts are needed to decrease the mortality of COVID-19-infected ESKD patients.

Topics & Concepts

Renal replacement therapyMedicineCoronavirus disease 2019 (COVID-19)Intensive care medicineKidney diseaseIsolation (microbiology)DialysisEnd-stage kidney diseaseHemodialysisDiseaseUremiaEnd stage renal diseaseCoronavirusStage (stratigraphy)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Acute kidney injuryOutbreakInternal medicineInfectious disease (medical specialty)VirologyBioinformaticsBiologyPaleontologyCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19SARS-CoV-2 and COVID-19 Research